Clinical Trials Browser

OTHER × Bone Diseases, Metabolic × Zoledronic Acid × Clear all

NCT01623908 2021-06-22

BLAZE

Phase NA Terminated

Bone Diseases, Metabolic, Breast Neoplasms

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Phase 2 Completed

Bone Diseases, Metabolic, Prostatic Neoplasms

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Phase 3 Completed

135 enrolled 4 charts

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin